Clinical Trial Update: A Study of the Effectiveness and Safety of Prolonged-release Methylphenidate Hydrochloride in Adult Patients With Attention Deficit/Hyperactivity Disorder. [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the effectiveness and safety of prolonged-release methylphenidate hydrochloride in adults with Attention-Deficit/Hyperactivity Disorder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• CONCERTA (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

Sponsor: Janssen Pharmaceutica N.V., Belgium | Conditions: Attention Deficit Disorder With Hyperactivity | Phase 3 | Status: COMPLETED